Twenty‐four‐week safety and tolerability of nevirapine <i>vs.</i> abacavir in combination with zidovudine/lamivudine as first‐line antiretroviral therapy: a randomized double‐blind trial (NORA)<sup>*</sup>
TM & IH. Tropical medicine and international health/TM & IH. Tropical medicine & international health